🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST. (SUIVICOLO)

RecruitingPhase 3Ages 50 Years - 75 YearsAllUniversity Hospital, Caen
NCT07520578 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To be effective, organized colorectal cancer screening requires good adherence to diagnostic colonoscopy in the event of a positive test. In France, the rate of diagnostic colonoscopy following a positive colorectal cancer screening test is less than 85%, and the median delay is close to 90 days. After receiving their positive result from the laboratory, individuals with no known follow-up are contacted only six months later by the Regional Cancer Screening Coordination Centers (CRCDC) responsible for following up with individuals who have tested positive. To optimize follow-up with colonoscopy, earlier contact and information about colonoscopy appear to be necessary. The contribution of the general practitioner identified on the test could be an additional lever. The SUIVICOLO study aims to evaluate the effectiveness on the rate of colonoscopies performed at 6 months of two strategies

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged between 50 and 75 at the time of the positive colorectal cancer screening test * Residing in one of the departments of the Centre Val de Loire region * Date on which the positive CRC screening test result was sent to the beneficiary recorded * Colorectal cancer screening test results sent to the beneficiary within 30 days of the test being read * Affiliated with a health insurance fund Exclusion Criteria: * Subjects who have notified their refusal to allow their data to be used for research purposes will be excluded from the analyses.
💊

What it tests

  • Usual care follow-up by CRCDC
  • Information leaflet about colonoscopy follow-up
  • Endorsement of CRCDC letters from the GP
📍

Where

1 site
Crcdc-Cvl
Tours, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy